Showing results (61-70 of 136) with videos related to

Sort By:
Pageof 14
Circulation Research|August 16, 2003
Role of phosphodiesterase 3 in NO/cGMP-mediated antiinflammatory effects in vascular smooth muscle cellsToru Aizawa, Heng Wei, Joseph M Miano, et al.
Internal Medicine (Tokyo, Japan)|May 16, 2017
Graves' Disease in Pediatric and Elderly Patients with 22q11.2 Deletion SyndromeYoko Ueda, Shinsuke Uraki, Hidefumi Inaba, et al.
Endocrine Journal|June 9, 2015
Clinicopathological features of Riedel's thyroiditis associated with IgG4-related disease in JapanKen Takeshima, Hidefumi Inaba, Hiroyuki Ariyasu, et al.
Endocrine Journal|March 11, 2003
Pituitary adenomas in adolescent patients with multiple endocrine neoplasia type 1Ako Oiwa, Akihiro Sakurai, Yoshihiko Sato, et al.
Acta Diabetologica|February 2, 2019
Prediabetes defined by the International Expert Committee as a risk for development of glomerular hyperfiltrationIori Kawata, Tomomichi Koshi, Kazuko Hirabayashi, et al.
Journal of Molecular and Cellular Cardiology|December 30, 2004
Angiotensin II increases phosphodiesterase 5A expression in vascular smooth muscle cells: a mechanism by which angiotensin II antagonizes cGMP signalingDongsoo Kim, Toru Aizawa, Heng Wei, et al.
Acta Diabetologica|July 28, 2012
Index of glucose effectiveness derived from oral glucose tolerance testShoichiro Nagasaka, Ikuyo Kusaka, Koh Yamashita, et al.
Pageof 14